Following the results of the EMPA-REG OUTCOME trial with empagliflozin, is it possible to speak of a class effect?
Ampudia-Blasco, Francisco Javier, Romera, Irene, Ariño, Bernat, Gomis, RamónVolume:
Volume 10
Langue:
english
Journal:
International Journal of General Medicine
DOI:
10.2147/IJGM.S115566
Date:
January, 2017
Fichier:
PDF, 145 KB
english, 2017